The Offer of Neurosurgery Care in the Grand Est of France During the Health Crisis Linked to Covid-19

COVID-19 Pandemic Clinical Trial

— NeurochirCOVID  

Official title:

The Offer of Neurosurgery Care in the Grand Est of France During the Health Crisis Linked to Covid-19

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04701905
• Other study ID #: 7780
• Status: Recruiting
• Start date: April 30, 2020
• Est. completion date: April 30, 2021

Study information

• Verified date: January 2021
• Source: University Hospital, Strasbourg, France
• Contact: François PROUST, MD, PhD
• Phone: 33 3 88 12 76 12
• Email: francois.proust[@]chru-strasbourg.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

During this exceptional health crisis, this study of the current care of a neurosurgical activity, which is essential in a University Hospital Centre, will enable us to better understand how we function, the response given to a population with the means at our disposal, the implementation of new therapeutic strategies and their limits, ethical reflection, and, how to pursue a distributive and quality medicine. The restriction of conventional medical resources to our care activity (resuscitation, personnel, operating theatre, constraints linked to the risk of contamination...) is leading to a new medical organisation imposing new Covid-19 standards, the description of which seems essential to us. A knowledge of the strategies to be adopted during a disaster health situation in order to continue providing care to the civilian population. How can we prevent the setting up of health care systems outside the cause of the health crisis? n triage medicine, Avoiding the "burn-out" of doctors struck by the health crisis.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 450
• Est. completion date: April 30, 2021
• Est. primary completion date: April 30, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient aged over 18;
• Entering the neurosurgery care sector requiring support between 03/16/2020 and 06/15/2020;
• Having not expressed his opposition, after information, to the reuse of his data for the purposes of this research.

Exclusion Criteria:

• Subject having expressed opposition to participating in the study
• Subject under guardianship or guardianship
• Subject under safeguard of justice

Related Conditions & MeSH terms

• COVID-19 Pandemic

Locations

Country	Name	City	State
France	Department of Neurosurgery - Strasbourg University Hospitals	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Retrospective analysis of the management of neurosurgical pathologies in a health crisis situation of the Covid-19 pandemic		The files analysed retrospectily from March 16, 2020 to June 15, 2020 will be examined]